Liver Disease Clinical Trials in Illinois

66 recruiting studies across 1 city

Browse by City

All Trials in Illinois

Phase

Trial	Phase	Sponsor	Dist.
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	2 mi
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )	Phase 3	Inventiva Pharma	2 mi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH	Phase 3	89bio, Inc.	2 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	2 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	2 mi
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection	Phase 2/3	Bluejay Therapeutics, Inc.	2 mi
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)	—	Target PharmaSolutions, Inc.	2 mi
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation	—	University of Alberta	2 mi
miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial	Phase 1	Miromatrix Medical Inc.	2 mi
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study	Phase 2	Intercept Pharmaceuticals	2 mi
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant	—	University of Chicago	2 mi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis	Phase 3	Gilead Sciences	2 mi
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)	Phase 3	Mirum Pharmaceuticals, Inc.	2 mi
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease	N/A	Indiana University	2 mi
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).	Phase 2	NorthSea Therapeutics B.V.	2 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	2 mi
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients	—	Northwestern University	2 mi
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease	Phase 2	Justin Ryder	2 mi
Functional Assessment in Liver Transplantation	—	University of California, San Francisco	2 mi
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs	—	European Foundation for Study of Chronic Liver Failure	2 mi
Genetic Collection Protocol	—	Arbor Research Collaborative for Health	2 mi
Longitudinal Study of the Porphyrias	—	Icahn School of Medicine at Mount Sinai	2 mi
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease	—	University of Chicago	2 mi
TReatment for ImmUne Mediated PathopHysiology	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2 mi
HCV Tappt Adherence Study	N/A	University of Illinois at Chicago	2 mi
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors	N/A	Johns Hopkins University	2 mi
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)	N/A	University of Illinois at Chicago	2 mi
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)	Phase 2	Deciphera Pharmaceuticals, LLC	2 mi
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant	N/A	University of Pennsylvania	2 mi
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency	Phase 1/2	iECURE, Inc.	2 mi
A Prospective Database of Infants With Cholestasis	—	Arbor Research Collaborative for Health	2 mi
Primary Sclerosing Cholangitis in Children	—	Arbor Research Collaborative for Health	2 mi
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial	Phase 1	University of Chicago	2 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	2 mi
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)	N/A	Perspectum	2 mi
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition	—	Astellas Gene Therapies	2 mi
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	Phase 2	Mirum Pharmaceuticals, Inc.	2 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	2 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	—	HistoSonics, Inc.	2 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	2 mi
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)	N/A	ABK Biomedical	2 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)	Phase 1	AbbVie	2 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	2 mi
The Dragon PLC Trial (DRAGON-PLC)	N/A	Maastricht University	2 mi
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	Phase 2	Academic and Community Cancer Research United	2 mi
Optimizing Y90 Therapy for Radiation Lobectomy	—	Northwestern University	2 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	2 mi
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection	—	Northwestern University	2 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	2 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	2 mi
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years	Phase 4	Guerbet	2 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	2 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Phase 2	AstraZeneca	2 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Phase 3	ECOG-ACRIN Cancer Research Group	2 mi
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)	Phase 2/3	AbbVie	2 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors	Phase 1/2	Tango Therapeutics, Inc.	2 mi
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing	—	University of Chicago	2 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	Phase 1	Exelixis	2 mi
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment	—	Fresenius Kabi	2 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	2 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)	Phase 2	Daiichi Sankyo	12 mi
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)	Phase 3	89bio, Inc.	21 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Phase 3	Boehringer Ingelheim	21 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Phase 3	Boehringer Ingelheim	21 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer	Phase 2	AstraZeneca	27 mi
Integrated Cancer Repository for Cancer Research	—	University of Nebraska	37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.